Legal status · Australia
Is Ziconotide legal in Australia?
Written by Aaron CuhaReviewed Sep 2026
Direct answer
Yes. Ziconotide is an approved medicine in Australia, classified as "TGA-registered, prescription only". Approval covers its labeled indication and it is supplied on prescription, not over the counter. Products labeled "research use only" fall outside that approval and the label does not make human use lawful. On the evidence, 2 human studies are cited on its profile.
Ziconotide in Australia at a glance
| Classification | TGA-registered, prescription only |
|---|---|
| Note | Restricted to intrathecal use in specialist pain management. Not available in any other form. |
| TGA approval status | Approved by TGA for its labeled use |
| Human studies cited | 2 of 3 citations on the profile |
| Reviewed | Sep 2026 |
Classification and note come from the Ziconotide profile, checked against Therapeutic Goods Administration (TGA) listings at the reviewed date.
What this means
- 01
TGA has approved Ziconotide for at least one labeled indication, so a pharmaceutical-grade product exists in Australia and is dispensed on prescription.
- 02
Approval is indication-specific. Uses outside the label are a clinical decision for a prescriber, not something the approval itself authorizes.
- 03
Unlicensed online vials, including those labeled "research use only", are not the approved product and are not covered by the approval.
What Ziconotide is
A cone snail peptide approved in 2004 for severe chronic pain, given only by infusion into the spinal fluid through an implanted pump, with a boxed warning for severe psychiatric symptoms and neurological impairment. In its cancer and AIDS pain trial, 111 patients, mean pain score fell 53.1 percent against 18.1 percent on placebo. There is no oral, injected or topical version and there cannot be one.
Ziconotide is the synthetic form of a 25-amino-acid peptide from the venom of the marine cone snail Conus magus. The FDA approved it in December 2004 under NDA 021060 for the management of severe chronic pain in adults for whom intrathecal therapy is warranted, and who are intolerant of or refractory to other treatment, such as systemic analgesics, adjunctive therapies, or intrathecal morphine.
Mechanism: A selective antagonist of N-type voltage-gated calcium channels, which sit on the presynaptic terminals of primary nociceptive afferents in the dorsal horn of the spinal cord. Blocking calcium entry at those terminals prevents release of the neurotransmitters that carry the pain signal to second-order neurons.
Regulatory history: FDA-approved on 28 December 2004 under NDA 021060, for the management of severe chronic pain in adults for whom intrathecal therapy is warranted and who are intolerant of or refractory to other treatment. Intrathecal infusion is the only approved route. The label carries a boxed warning for severe psychiatric symptoms and neurological impairment.
How TGA treats this kind of product
Registers or lists therapeutic goods on the ARTG and schedules substances in the Poisons Standard. Many peptides are Schedule 4 (prescription only), so possession without a prescription and personal importation are restricted even when no product is registered.
The classification above is the The Longevity Archive reading of Therapeutic Goods Administration listings for Ziconotide at the reviewed date, not a legal opinion. Rules change, and importing, prescribing and possessing a compound can each be treated differently. Check the regulator directly before acting on anything here.
Ziconotide in other countries
Frequently asked questions
Is Ziconotide legal in Australia?
Yes. Ziconotide is an approved medicine in Australia, classified as "TGA-registered, prescription only". Approval covers its labeled indication and it is supplied on prescription, not over the counter. Products labeled "research use only" fall outside that approval and the label does not make human use lawful. On the evidence, 2 human studies are cited on its profile. Note: Restricted to intrathecal use in specialist pain management. Not available in any other form.
Can I buy Ziconotide in Australia?
Only with a prescription. Ziconotide is classified as "TGA-registered, prescription only" in Australia, so it is dispensed by pharmacies against a prescription for its approved indication. Buying it from unlicensed online sellers or as a "research chemical" is outside that system and carries no regulatory protection. Note: Restricted to intrathecal use in specialist pain management. Not available in any other form.
Is Ziconotide TGA approved?
Yes, for its labeled indication. In Australia Ziconotide is classified as "TGA-registered, prescription only". For comparison, the US FDA status is: FDA-approved on 28 December 2004 under NDA 021060, for the management of severe chronic pain in adults for whom intrathecal therapy is warranted and who are intolerant of or refractory to other treatment. Intrathecal infusion is the only approved route. The label carries a boxed warning for severe psychiatric symptoms and neurological impairment.. On the evidence, 2 human studies are cited on its profile.
Related compounds in Australia
Full research profile
Mechanism, cited studies, FDA status and the full legal summary for Ziconotide live on its compound profile.
Ziconotide profileThis page is general information about the regulatory status of Ziconotide in Australia, current as of Sep 2026. It is not legal advice, and classifications change; check Therapeutic Goods Administration directly or consult a lawyer for a specific situation. Educational use only. This database summarizes published research. It is not medical advice and contains no dosing protocols or recommendations for personal use. The Longevity Archive has no vendor relationships and does not recommend where to buy anything.